Treace Medical Concepts, Inc. (TMCI)
NASDAQ: TMCI · Real-Time Price · USD
7.94
-0.04 (-0.50%)
Nov 21, 2024, 4:00 PM EST - Market closed
Treace Medical Concepts Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for TMCI stock have an average target of 7.40, with a low estimate of 6.00 and a high estimate of 8.00. The average target predicts a decrease of -6.80% from the current stock price of 7.94.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for TMCI stock from 6 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
---|---|---|---|---|---|---|
Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 7 | 7 | 7 | 7 | 6 | 6 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 7 | 7 | 7 | 7 | 6 | 6 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Stifel | Stifel | Hold Maintains $7 → $8 | Hold | Maintains | $7 → $8 | +0.76% | Nov 6, 2024 |
Truist Securities | Truist Securities | Hold Maintains $7.5 → $6 | Hold | Maintains | $7.5 → $6 | -24.43% | Oct 14, 2024 |
UBS | UBS | Hold Maintains $6.5 → $7 | Hold | Maintains | $6.5 → $7 | -11.84% | Aug 7, 2024 |
Truist Securities | Truist Securities | Hold Maintains $9 → $7.5 | Hold | Maintains | $9 → $7.5 | -5.54% | Aug 7, 2024 |
Truist Securities | Truist Securities | Hold Maintains $7 → $9 | Hold | Maintains | $7 → $9 | +13.35% | Jul 16, 2024 |
Financial Forecast
Revenue This Year
211.72M
from 187.12M
Increased by 13.15%
Revenue Next Year
229.43M
from 211.72M
Increased by 8.36%
EPS This Year
-0.94
from -0.81
EPS Next Year
-0.77
from -0.94
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 218.7M | 239.1M | 271.1M | ||
Avg | 211.7M | 229.4M | 251.3M | ||
Low | 202.9M | 219.1M | 234.8M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 16.9% | 12.9% | 18.2% | ||
Avg | 13.1% | 8.4% | 9.5% | ||
Low | 8.4% | 3.5% | 2.3% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | -0.96 | -0.74 | -0.64 | ||
Avg | -0.94 | -0.77 | -0.69 | ||
Low | -0.94 | -0.86 | -0.74 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.